Audio player

Comments

Moderna's chief medical officer on its blockbuster vaccine news

Axios Re:Cap

Technology

Moderna Therapeutics today reported a 94.5% efficacy for its COVID-19 vaccine, which needn't be stored at the same ultra-cold temperatures as does a similar vaccine developed by Pfizer. It also said short-term safety concerns, such as headaches and injection site soreness, self-resolved within days, and that it could have 20 million doses available by year-end. Dan speaks with Moderna chief medical officer Tal Zaks about the new data, distribution, politics, and how it was preparing for this moment even before COVID-19 was discovered. Learn more about your ad choices. Visit megaphone.fm/adchoices


More episodes  


Listen to Robert Downey Jr. and his partners on their new clean-tech venture

Robert Downey Jr. and his partners on their new clean-tech venture

Jan 27, 2021
Listen to Reddit Is Running Wall Street

Reddit Is Running Wall Street

Jan 26, 2021
Listen to Google's chief health officer Karen DeSalvo on vaccinating America

Google's chief health officer Karen DeSalvo on vaccinating America

Jan 25, 2021
Listen to Carbon Health's CEO on unsticking the vaccine bottleneck

Carbon Health's CEO on unsticking the vaccine bottleneck

Jan 22, 2021
Listen to The future of net neutrality under Biden

The future of net neutrality under Biden

Jan 21, 2021
:: / ::
1.0x 1.5x 2.0x